Detalles de la búsqueda
1.
Real-world management patterns in EGFR-mutant advanced non-small-cell lung cancer before first-line adoption of osimertinib: the REFLECT study in Greece.
Future Oncol;
18(28): 3151-3164, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35929414
2.
Cancer-related neuropathic pain in out-patient oncology clinics: a European survey.
BMC Palliat Care;
12(1): 41, 2013 Nov 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-24200014
3.
Incidence of Disease Recurrence in Patients With Colon and Upper Rectum Adenocarcinoma Stage II and III Receiving Adjuvant Capecitabine Monotherapy: Do Number of Chemotherapy Cycles and Relative Dose Intensity of the Drug Play a Role?
Clin Colorectal Cancer;
22(2): 238-244, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36967268
4.
Real-world Data and Economic Evaluation of Nivolumab in Previously Treated Non-small Cell Lung Cancer Greek Patients.
Anticancer Res;
43(6): 2799-2812, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37247889
5.
Clinical Outcomes Beyond 1L EGFR-TKI Progression in mNSCLC: Final Results of the Real-World Study 'LUNGFUL'.
Anticancer Res;
43(5): 2243-2258, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37097667
6.
The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial.
Breast Cancer Res;
14(6): R145, 2012 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-23146280
7.
XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis.
BMC Cancer;
12: 271, 2012 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-22748098
8.
A Multicenter, Prospective, Observational Study to Assess the Clinical Activity and Impact on Symptom Burden and Patients' Quality of Life in Patients with Advanced Soft Tissue Sarcomas Treated with Trabectedin in a Real-World Setting in Greece.
Cancers (Basel);
14(8)2022 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35454787
9.
Validation of Patras Immunotherapy Score model for prediction and prognosis of patients with advanced NSCLC treated with nivolumab or pembrolizumab: results from a European multicentre study.
Ther Adv Med Oncol;
14: 17588359221122728, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36105886
10.
A Real-World, Observational, Prospective Study to Assess the Molecular Epidemiology of Epidermal Growth Factor Receptor (EGFR) Mutations upon Progression on or after First-Line Therapy with a First- or Second-Generation EGFR Tyrosine Kinase Inhibitor in EGFR Mutation-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer: The 'LUNGFUL' Study.
Cancers (Basel);
13(13)2021 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34202063
11.
A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study.
BMC Med;
8: 3, 2010 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-20055981
12.
Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Breast Cancer Res Treat;
116(1): 131-43, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18668363
13.
Pegfilgrastim administered on the same day with dose-dense adjuvant chemotherapy for breast cancer is associated with a higher incidence of febrile neutropenia as compared to conventional growth factor support: matched case-control study of the Hellenic Cooperative Oncology Group.
Oncology;
77(2): 107-12, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19622901
14.
Genotyping KRAS and EGFR Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment.
Cancer Genomics Proteomics;
16(6): 531-541, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31659106
15.
Prognostic Impact of Src, CDKN1B, and JAK2 Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab.
Transl Oncol;
12(5): 739-748, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-30877976
16.
Gemcitabine combined with gefitinib in patients with inoperable or metastatic pancreatic cancer: a phase II Study of the Hellenic Cooperative Oncology Group with biomarker evaluation.
Cancer Invest;
26(8): 784-93, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-18798073
17.
Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomised trials conducted by the Hellenic Cooperative Oncology Group.
Anticancer Res;
28(5B): 2913-20, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-19031934
18.
Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients.
Anticancer Res;
27(6C): 4481-9, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-18214064
19.
Effective use of levosimendan in anthracycline-induced cardiomyopathy: A case report.
Heart Lung;
46(5): 382-386, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28733066
20.
Combination of topotecan and cisplatin in relapsed patients with small cell lung cancer: a phase II study of the hellenic cooperative oncology group (HeCOG).
Cancer Chemother Pharmacol;
57(2): 207-12, 2006 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-16028103